Items where Author is "Hawkins, N"

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Year | Item Type | Full Text
Jump to: 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003
Number of items: 58.

2017

Saffioti, F; Gurusamy, KS; Hawkins, N; Toon, CD; Tsochatzis, E; Davidson, BR; Thorburn, D; (2017) Pharmacological interventions for primary sclerosing cholangitis: an attempted networkmeta-analysis. Cochrane Database of Systematic Reviews (3). p. 91. ISSN 1469-493X DOI: 10.1002/14651858.CD011343.pub2 Item availability may be restricted.
[img]

2016

Thompson, JC; Quigley, JM; Halfpenny, NJ; Scott, DA; Hawkins, NS; (2016) Importance and methods of searching for E-publications ahead of print in systematic reviews. Evidence-based medicine. ISSN 1356-5524 DOI: 10.1136/ebmed-2015-110374 Full text not available from this repository.

2015

Govan, L; Wu, O; Xin, Y; Hutchinson, SJ; Hawkins, N; (2015) Comparative effectiveness of antiviral treatment for hepatitis B. European journal of gastroenterology & hepatology, 27 (8). pp. 882-94. ISSN 0954-691X DOI: 10.1097/MEG.0000000000000376 Full text not available from this repository.

Lipton, JH; Bryden, P; Sidhu, MK; Huang, H; McGarry, LJ; Lustgarten, S; Mealing, S; Woods, B; Whelan, J; Hawkins, N; (2015) Comparative efficacy of tyrosine kinase inhibitor treatments in the third-line setting, for chronic-phase chronic myelogenous leukemia after failure of second-generation tyrosine kinase inhibitors. Leukemia research, 39 (1). pp. 58-64. ISSN 0145-2126 DOI: 10.1016/j.leukres.2014.10.005 Full text not available from this repository.

Woods, B; Hawkins, N; Mealing, S; Sutton, A; Abraham, WT; Beshai, JF; Klein, H; Sculpher, M; Plummer, CJ; Cowie, MR; (2015) Individual patient data network meta-analysis of mortality effects of implantable cardiac devices. Heart (British Cardiac Society). ISSN 1355-6037 DOI: 10.1136/heartjnl-2015-307634
[img]

2014

Fletcher, C; Chuang-Stein, C; Paget, MA; Reid, C; Hawkins, N; (2014) Subgroup analyses in cost-effectiveness analyses to support health technology assessments. Pharmaceutical statistics, 13 (4). pp. 265-74. ISSN 1539-1604 DOI: 10.1002/pst.1626 Full text not available from this repository.

Goring, S; Hawkins, N; Wygant, G; Roudaut, M; Townsend, R; Wood, I; Barnett, AH; (2014) Dapagliflozin compared with other oral anti-diabetes treatments when added to metformin monotherapy: A systematic review and network meta-analysis. Diabetes, obesity & metabolism, 16. pp. 433-442. ISSN 1462-8902 DOI: 10.1111/dom.12239 Full text not available from this repository.

Laws, A; Kendall, R; Hawkins, N; (2014) A comparison of national guidelines for network meta-analysis. Value in health , 17 (5). pp. 642-54. ISSN 1098-3015 DOI: 10.1016/j.jval.2014.06.001 Full text not available from this repository.

Mealing, S; Ghement, I; Hawkins, N; Scott, DA; Lescrauwaet, B; Watt, M; Thursz, M; Lampertico, P; Mantovani, L; Morais, E; +2 more... (2014) The importance of baseline viral load when assessing relative efficacy in treatment-naïve HBeAg-positive chronic hepatitis B: a systematic review and network meta-analysis. Systematic reviews, 3. p. 21. ISSN 2046-4053 DOI: 10.1186/2046-4053-3-21
[img]

Ortega, A; Fraga, MD; Alegre-del-Rey, EJ; Puigventós-Latorre, F; Porta, A; Ventayol, P; Tenias, JM; Hawkins, NS; Caldwell, DM; (2014) A checklist for critical appraisal of indirect comparisons. International journal of clinical practice, 68. pp. 1181-9. ISSN 1368-5031 DOI: 10.1111/ijcp.12487 Full text not available from this repository.

Wong, CM; Hawkins, NM; Petrie, MC; Jhund, PS; Gardner, RS; Ariti, CA; Poppe, KK; Earle, N; Whalley, GA; Squire, IB; +3 more... (2014) Heart failure in younger patients: the Meta-analysis Global Group in Chronic Heart Failure (MAGGIC). European heart journal. ISSN 0195-668X DOI: 10.1093/eurheartj/ehu216 Full text not available from this repository.

2013

2012

Hawkins, N; Laws, A; Kendall, R; (2012) Comparison of National Guidelines for Indirect Network Meta-Analysis. p. 2012. Full text not available from this repository.

Hawkins, N; Richardson, G; Sutton, AJ; Cooper, NJ; Griffiths, C; Rogers, A; Bower, P; (2012) Surrogates, meta-analysis and cost-effectiveness modelling: a combined analytic approach. Health economics, 756. pp. 742-756. ISSN 1057-9230 DOI: 10.1002/hec.1741 Full text not available from this repository.

Woods, B; Hawkins, N; Dunlop, W; O'Toole, A; Bramham-Jones, S; (2012) Bendamustine versus chlorambucil for the first-line treatment of chronic lymphocytic leukemia in England and Wales: A cost-utility analysis. Value in health , 15 (5). pp. 759-70. ISSN 1098-3015 DOI: 10.1016/j.jval.2012.03.1389 Full text not available from this repository.

2011

Bujkiewicz, S; Jones, HE; Lai, MC; Cooper, NJ; Hawkins, N; Squires, H; Abrams, KR; Spiegelhalter, DJ; Sutton, AJ; (2011) Development of a transparent interactive decision interrogator to facilitate the decision-making process in health care. Value in health , 14 (5). pp. 768-76. ISSN 1098-3015 DOI: 10.1016/j.jval.2010.12.002
[img]

Gross, JL; Kramer, CK; Leitão, CB; Hawkins, N; Viana, LV; Schaan, BD; Pinto, LC; Rodrigues, TC; Azevedo, MJ; (2011) Effect of antihyperglycemic agents added to metformin and a sulfonylurea on glycemic control and weight gain in type 2 diabetes: A network meta-analysis. Annals of internal medicine, 154. pp. 672-679. ISSN 0003-4819 DOI: 10.7326/0003-4819-154-10-201105170-00007 Full text not available from this repository.

Hawkins, N; Richardson, G; Sutton, AJ; Cooper, NJ; Griffiths, C; Rogers, A; Bower, P; (2011) SURROGATES , META ‐ ANALYSIS AND COST ‐ EFFECTIVENESS MODELLING : A COMBINED ANALYTIC APPROACH. DOI: 10.1002/hec Full text not available from this repository.

Hawkins, N; Scott, DA; (2011) REIMBURSEMENT AND VALUE-BASED PRICING : STRATIFIED COST-EFFECTIVENESS ANALYSIS MAY NOT BE THE LAST WORD. Health economics, 20 (6). pp. 688-98. ISSN 1057-9230 DOI: 10.1002/hec.1625 Full text not available from this repository.

Hoaglin, DC; Hawkins, N; Jansen, JP; Scott, DA; Itzler, R; Cappelleri, JC; Boersma, C; Thompson, D; Larholt, KM; Diaz, M; +1 more... (2011) Conducting indirect-treatment-comparison and network-meta-analysis studies: report of the ISPOR Task Force on Indirect Treatment Comparisons Good Research Practices: part 2. Value in health , 14 (4). pp. 429-37. ISSN 1098-3015 DOI: 10.1016/j.jval.2011.01.011 Full text not available from this repository.

Jansen, JP; Fleurence, R; Devine, B; Itzler, R; Barrett, A; Hawkins, N; Lee, K; Boersma, C; Annemans, L; Cappelleri, JC; (2011) Interpreting indirect treatment comparisons and network meta-analysis for health-care decision making: Report of the ISPOR task force on indirect treatment comparisons good research practices: Part 1. Value in health , 14 (4). pp. 417-28. ISSN 1098-3015 DOI: 10.1016/j.jval.2011.04.002 Full text not available from this repository.

Woods, B; Veenstra, D; Hawkins, N; (2011) Prioritizing pharmacogenetic research: A value of information analysis of CYP2D6 testing to guide breast cancer treatment. Value in Health, 14. pp. 989-1001. ISSN 1465-1858 DOI: 10.1016/j.jval.2011.05.048 Full text not available from this repository.

2010

Chambers, D; Worthy, G; Myers, L; Weatherly, H; Elliott, R; Hawkins, N; Sculpher, M; Eastwood, A; (2010) Glycopeptide vs. non-glycopeptide antibiotics for prophylaxis of surgical site infections: a systematic review. Surgical infections, 11. pp. 455-462. ISSN 1096-2964 DOI: 10.1089/sur.2009.055 Full text not available from this repository.

Hawkins, N; Scott, DA; (2010) Placebo at Your Peril. DOI: 10.1177/0272989X10362106 Full text not available from this repository.

Hawkins, N; Scott, DA; (2010) Cost-effectiveness analysis: discount the placebo at your peril. Medical decision making , 30. pp. 536-43. ISSN 0272-989X DOI: 10.1177/0272989X10362106 Full text not available from this repository.

Hawkins, NS; Cranny, Æ, G; Chambers, Æ, D; Myers, L; Eastwood, Æ, A; Sculpher, Æ, MJ; Elliott, RA; Weatherly, HLA; Hawkins, NS; Cranny, G; +4 more... (2010) An economic model for the prevention of MRSA infections after surgery: Non-glycopeptide or glycopeptide antibiotic prophylaxis? The European journal of health economics , 11. pp. 57-66. ISSN 1618-7598 DOI: 10.1007/s10198-009-0175-0 Full text not available from this repository.

McKenna, C; Hawkins, N; Claxton, K; McDaid, C; Suekarran, S; Light, K; Chester, M; Cleland, JGF; Woolacott, N; Sculpher, M; (2010) Cost-effectiveness of enhanced external counterpulsation (EECP) for the treatment of stable angina in the United Kingdom. International journal of technology assessment in health care, 26. pp. 175-82. ISSN 0266-4623 DOI: 10.1017/S0266462310000073 Full text not available from this repository.

Punekar, YS; Sunderland, T; Hawkins, N; Lindsay, J; (2010) Cost-effectiveness of scheduled maintenance treatment with infliximab for pediatric Crohn's disease. Value in health , 13. pp. 188-195. ISSN 1098-3015 DOI: 10.1111/j.1524-4733.2009.00658.x Full text not available from this repository.

2009

Hawkins, N; Scott, DA; Woods, B; (2009) How far do you go? Efficient searching for indirect evidence. Medical decision making , 29 (3). pp. 273-81. ISSN 0272-989X DOI: 10.1177/0272989X08330120 Full text not available from this repository.

Hawkins, N; Scott, DA; Woods, BS; Thatcher, N; (2009) No study left behind: a network meta-analysis in non-small-cell lung cancer demonstrating the importance of considering all relevant data. Value in health , 12 (6). pp. 996-1003. ISSN 1098-3015 DOI: 10.1111/j.1524-4733.2009.00541.x Full text not available from this repository.

McKenna, C; Palmer, S; Rodgers, M; Chambers, D; Hawkins, N; Golder, S; van Hout, S; Pepper, C; Todd, D; Woolacott, N; (2009) Cost-effectiveness of radiofrequency catheter ablation for the treatment of atrial fibrillation in the United Kingdom. Heart (British Cardiac Society), 95. pp. 542-549. ISSN 1355-6037 DOI: 10.1136/hrt.2008.147165 Full text not available from this repository.

2008

Cranny, G; Elliott, R; Weatherly, H; Chambers, D; Hawkins, N; Myers, L; Sculpher, M; Eastwood, A; (2008) A systematic review and economic model of switching from non-glycopeptide to glycopeptide antibiotic prophylaxis for surgery. Health technology assessment (Winchester, England), 12 (1). iii-iv, xi-xii, 1-147. ISSN 1366-5278 Full text not available from this repository.

Ryan, M; Griffin, S; Chitah, B; Walker, AS; Mulenga, V; Kalolo, D; Hawkins, N; Merry, C; Barry, MG; Chintu, C; +2 more... (2008) The cost-effectiveness of cotrimoxazole prophylaxis in HIV-infected children in Zambia. AIDS (London, England), 22. pp. 749-57. ISSN 0269-9370 DOI: 10.1097/QAD.0b013e3282f43519 Full text not available from this repository.

2007

Bravo Vergel, Y; Hawkins, NS; Claxton, K; Asseburg, C; Palmer, S; Woolacott, N; Bruce, IN; Sculpher, MJ; (2007) The cost-effectiveness of etanercept and infliximab for the treatment of patients with psoriatic arthritis. Rheumatology (Oxford, England), 46. pp. 1729-35. ISSN 1462-0324 DOI: 10.1093/rheumatology/kem221 Full text not available from this repository.

Hawkins, N; Claxton, K; Light, K; (2007) Etanercept and Infliximab for the Treatment of Psoriatic Arthritis. Full text not available from this repository.

Thomas, M; Care, P; Medicine, R; Doull, I; Price, D; Thomas, M; Hawkins, N; Stamuli, E; Tabberer, M; Gosden, T; +1 more... (2007) Cost-effectiveness of salmeterol xinafoate/fluticasone propionate combination inhaler in chronic asthma. Current medical research and opinion, 23. pp. 1147-59. ISSN 0300-7995 DOI: 10.1185/030079907X187982 Full text not available from this repository.

2006

Griffin, S; Claxton, K; Hawkins, N; Sculpher, M; (2006) Probabilistic analysis and computationally expensive models: Necessary and required? Value in health , 9. pp. 244-252. ISSN 1098-3015 DOI: 10.1111/j.1524-4733.2006.00107.x Full text not available from this repository.

Richardson, G; Hawkins, N; McCarthy, CJ; Mills, PM; Pullen, R; Roberts, C; Silman, A; Oldham, JA; (2006) Cost-effectiveness of a supplementary class-based exercise program in the treatment of knee osteoarthritis. International journal of technology assessment in health care, 22 (1). pp. 84-9. ISSN 0266-4623 Full text not available from this repository.

Woolacott, N; Bravo Vergel, Y; Hawkins, N; Kainth, A; Khadjesari, Z; Misso, K; Light, K; Asseburg, C; Palmer, S; Claxton, K; +3 more... (2006) Etanercept and infliximab for the treatment of psoriatic arthritis: a systematic review and economic evaluation. Health technology assessment (Winchester, England), 10. iii-iv, xiii-xvi, 1-239. ISSN 1366-5278 Full text not available from this repository.

Woolacott, N; Hawkins, N; Mason, A; Al., E; (2006) Etanercept and efalizumab for the treatment of psoriasis: a systematic review. Health technology assessment (Winchester, England), 10. 1-233, i-iv. ISSN 1366-5278 DOI: 03/26/01 [pii] Full text not available from this repository.

2005

Hawkins, N; Epstein, D; Drummond, M; Wilby, J; (2005) Assessing the Cost-Effectiveness of New Pharmaceuticals in Epilepsy in Adults :. pp. 493-510. Full text not available from this repository.

Hawkins, N; Epstein, D; Drummond, M; Wilby, J; Kainth, A; Chadwick, D; Sculpher, M; (2005) Assessing the cost-effectiveness of new pharmaceuticals in epilepsy in adults: the results of a probabilistic decision model. Medical decision making , 25. pp. 493-510. ISSN 0272-989X DOI: 10.1177/0272989X05280559 Full text not available from this repository.

Hawkins, N; Sculpher, M; Epstein, D; (2005) Cost-effectiveness analysis of treatments for chronic disease: using R to incorporate time dependency of treatment response. Medical decision making , 25 (5). pp. 511-9. ISSN 0272-989X DOI: 10.1177/0272989X05280562 Full text not available from this repository.

Manca, A; Hawkins, N; Sculpher, MJ; (2005) Estimating mean QALYs in trial-based cost-e ¡ ectiveness analysis : the importance of controlling for baseline utility. pp. 487-496. DOI: 10.1002/hec.944 Full text not available from this repository.

Wilby, J; Kainth, A; Hawkins, N; Epstein, D; McIntosh, H; McDaid, C; Mason, A; Golder, S; O'Meara, S; Sculpher, M; +2 more... (2005) Clinical effectiveness, tolerability and cost-effectiveness of newer drugs for epilepsy in adults: a systematic review and economic evaluation. Health technology assessment (Winchester, England), 9. 1-157, iii-iv. ISSN 1366-5278 DOI: 01-50-01 [pii] Full text not available from this repository.

2004

Jones, L; Griffin, S; Palmer, S; Main, C; Orton, V; Sculpher, M; Sudlow, C; Henderson, R; Hawkins, N; Riemsma, R; (2004) Clinical effectiveness and cost-effectiveness of clopidogrel and modified-release dipyridamole in the secondary prevention of occlusive vascular events: A systematic review and economic evaluation. Health technology assessment (Winchester, England), 8 (38). iii-iv, 1-196. ISSN 1366-5278 Full text not available from this repository.

Jones, L; Hawkins, N; Westwood, M; Wright, K; Richardson, G; Riemsma, R; (2004) Systematic review of the clinical effectiveness and cost-effectiveness of capecitabine (Xeloda) for locally advanced and/or metastatic breast cancer. Health technology assessment (Winchester, England), 8 (5). iii, xiii-xvi, 1-143. ISSN 1366-5278 Full text not available from this repository.

Main, C; Palmer, S; Griffin, S; Jones, L; Orton, V; Sculpher, M; Henderson, R; Sudlow, C; Hawkins, N; Riemsma, R; (2004) Clopidogrel used in combination with aspirin compared with aspirin alone in the treatment of non-ST-segment-elevation acute coronary syndromes: a systematic review and economic evaluation. Health technology assessment (Winchester, England), 8 (40). iii-iv, xv-xvi, 1-141. ISSN 1366-5278 Full text not available from this repository.

McCarthy, CJ; Mills, PM; Pullen, R; Richardson, G; Hawkins, N; Roberts, CR; Silman, AJ; Oldham, JA; (2004) Supplementation of a home-based exercise programme with a class-based programme for people with osteoarthritis of the knees: A randomised controlled trial and health economic analysis. Health technology assessment (Winchester, England), 8. p. 2015. ISSN 1366-5278 DOI: 10.3310/hta8460 Full text not available from this repository.

2003

This list was generated on Mon Sep 25 06:40:36 2017 BST.